| Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020 J Liu, X Liao, S Qian, J Yuan, F Wang, Y Liu, Z Wang, FS Wang, L Liu, ... Emerging infectious diseases 26 (6), 1320, 2020 | 1160 | 2020 |
| The role of hepatitis B surface antigen in nucleos (t) ide analogues cessation among asian patients with chronic hepatitis B: a systematic review J Liu, T Li, L Zhang, A Xu Hepatology 70 (3), 1045-1055, 2019 | 112 | 2019 |
| Longitudinal Changes of Liver Function and Hepatitis B Reactivation in COVID‐19 Patients with Pre‐existing Chronic HBV Infection J Liu, T Wang, Q Cai, L Sun, D Huang, G Zhou, Q He, FS Wang, L Liu, ... Hepatology Research, 2020 | 73* | 2020 |
| Effect of combination treatment based on interferon and nucleos (t) ide analogues on functional cure of chronic hepatitis B: a systematic review and meta-analysis J Liu, T Wang, W Zhang, Y Cheng, Q He, FS Wang Hepatology international 14, 958-972, 2020 | 33 | 2020 |
| Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review J Lv, H Wu, J Xu, J Liu Infectious Diseases of Poverty 11 (1), 53, 2022 | 28 | 2022 |
| Immune response to hepatitis B vaccine in patients with chronic hepatitis C infection: A systematic review and meta‐analysis J Liu, H Wu, H Chen Hepatology Research 48 (2), 119-126, 2018 | 25 | 2018 |
| Immune restoration in HIV-1-infected patients after 12 years of antiretroviral therapy: a real-world observational study J Liu, L Wang, Y Hou, Y Zhao, Z Dou, Y Ma, D Zhang, Y Wu, D Zhao, Z Liu, ... Emerging Microbes & Infections 9 (1), 2550-2561, 2020 | 23 | 2020 |
| Comparison between two population-based hepatitis B serosurveys with an 8-year interval in Shandong Province, China J Liu, J Lv, B Yan, Y Feng, L Song, A Xu, L Zhang, Y Yan International Journal of Infectious Diseases 61, 13-19, 2017 | 17 | 2017 |
| Comparison of hepatitis E virus seroprevalence between HBsAg-positive population and healthy controls in Shandong province, China L Zhang, Z Jiang, J Lv, J Liu, B Yan, Y Feng, L Li, G Zhang, F Wang, A Xu BMC Infectious Diseases 18, 1-9, 2018 | 16 | 2018 |
| Human umbilical cord mesenchymal stem cell transfusion in immune non-responders with AIDS: a multicenter randomized controlled trial L Wang, Z Zhang, R Xu, X Wang, Z Shu, X Chen, S Wang, J Liu, Y Li, ... Signal transduction and targeted therapy 6 (1), 217, 2021 | 14 | 2021 |
| High population-attributable fractions of traditional risk factors for non-AIDS-defining diseases among people living with HIV in China: a cohort study J Liu, Y Hou, L Sun, L Wang, Y He, Y Zhou, L Xu, X Liu, F Zhao, L Zhang, ... Emerging microbes & infections 10 (1), 416-423, 2021 | 12 | 2021 |
| Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years … LQ Sun, JY Liu, Y He, Y Zhou, LM Xu, LK Zhang, F Zhao, XN Liu, Y Song, ... Chinese medical journal 133 (23), 2808-2815, 2020 | 11 | 2020 |
| Barriers to early diagnosis and treatment of severely immunosuppressed patients with HIV‐1 infection: A quantitative and qualitative study JY Liu, LQ Sun, YY Hou, LF Wang, Y He, Y Zhou, LM Xu, H Wang, ... HIV medicine 21 (11), 708-717, 2020 | 7 | 2020 |
| Higher risk of dyslipidemia with coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide than efavirenz, lamivudine, and tenofovir disoproxil fumarate … L Sun, Y He, L Xu, F Zhao, Y Zhou, L Zhang, Q Peng, H Zhang, Q Zhang, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 91 (S1), S8-S15, 2022 | 5 | 2022 |
| Epidemiological trends of severely immunosuppressed people living with HIV at time of starting antiretroviral treatment in China during 2005–2018 Y Hou, J Liu, Y Zhao, Y Wu, Y Ma, D Zhao, Z Dou, Z Liu, M Shi, Y Jiao, ... Journal of Infection 84 (3), 400-409, 2022 | 5 | 2022 |
| Matching study on immune response between single anti-HBc positivity and healthy adults after primary immunization and revaccination of hepatitis B vaccine J Liu, J Lyu, B Yan, Y Feng, L Zhang, A Xu Zhonghua liu Xing Bing xue za zhi= Zhonghua Liuxingbingxue Zazhi 35 (10 …, 2014 | 5 | 2014 |
| Comparison on the Antibody Response and Influenced Factors of Hepatitis B Vacine Made by Recombinant Dexyribonucleic Acid Techniques among Adults J Liu, B Yan, L Zhang, J Lv, Y Feng, F Ji, S Chen, A Xu Chin. J. Vaccines Immun 19, 142-146, 2013 | 5 | 2013 |
| Total dietary flavonoid intake and risk of cardiometabolic diseases: A dose-response meta-analysis of prospective cohort studies T Li, Y Zhao, L Yuan, D Zhang, Y Feng, H Hu, D Hu, J Liu Critical Reviews in Food Science and Nutrition 64 (9), 2760-2772, 2024 | 4 | 2024 |
| Longitudinal changes on clinical features in 28 children with COVID-19 in Shenzhen, China X Liao, J Liu, Z He, M Hu, T Xiao, L Wei, Q Cai, H Wang, Q He, L Liu, ... Frontiers in Medicine 7, 738, 2020 | 4 | 2020 |
| Robust antibody and cytokine response to hepatitis b vaccine among not-in-treatment patients with chronic hepatitis C: an open-label control study in China J Liu, S Qiu, J Lu, B Yan, Y Feng, L Li, G Zhang, F Wang, P He, X Fang, ... The Journal of Infectious Diseases 216 (3), 327-335, 2017 | 4 | 2017 |
Tingyan WangSenior Data Scientist, University of Oxford確認したメール アドレス: ndm.ox.ac.uk
